Meeting
2012 Gastrointestinal Cancers Symposium
Effect of octreotide LAR on quality of life of 93 Hungarian patients with neuroendocrine tumors.
Authors
Tibor Gyökeres
MAV Hospital and Central Medical Clinic, Budapest, Hungary
Tibor Gyökeres , Sonia Pulgar , Neha Singh , Vanessa Q. Passos , Peter Kelemen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
CSMS995AHU02
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 362)
DOI
10.1200/jco.2012.30.4_suppl.362
Abstract #
362
Poster Bd #
F4
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Quality-of-life findings in patients with midgut neuroendocrine tumors: Results of the NETTER-1 phase III trial.
First Author: Jonathan R. Strosberg
Poster
2019 ASCO Annual Meeting
Analysis of patient diaries in the NETTER-1 Study of 177Lu-DOTATATE versus high-dose octreotide in progressive midgut neuroendocrine tumors.
First Author: Jonathan R. Strosberg
Poster
2020 ASCO Virtual Scientific Program
Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors.
First Author: Chunmei Bai
Poster
2018 Palliative and Supportive Care in Oncology Symposium
Impact of palliative care interventions on health-related quality of life (HRQOL): A secondary analysis of the Promoting Resilience in Stress Management (PRISM) Randomized Controlled Trial (RCT).
First Author: Angela Steineck